Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology ...

Brazilian President Luiz Inacio Lula da Silva successfully underwent a minimally invasive procedure to halt brain bleeding.

Noema Pharma extends its series B funding to $147M, advancing phase 2 trials for CNS disorders like Tourette syndrome, ...

Delix Therapeutics, a clinical-stage neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological disorders, today announced full results from the ...

Unlearn ® achieved key milestones in advancing AI to eliminate trial and error in medicine. From securing $50M in Series C funding to launching innovative tools and forming strategic partnerships, ...

BOSTON and CAMBRIDGE, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s ...

New therapies will allow patients greater choice and flexibility in the control of CNS disorders BARCELONA , Spain, DÜSSELDORF, Germany , and ATHENS, Greece , Dec.

Exposure to pesticides, such as organophosphates, synthetic pyrethroids, and neonicotinoids, is linked to memory and learning ...